A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old

NCT03257241 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

582

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: A arm (DA-90)
DRUG: B arm (DAC)
DRUG: A arm (CLAG-M)
DRUG: B arm (FLAG-IDA)

Sponsor

Polish Adult Leukemia Group